WhichRecall
Class I — UrgentReported 2025-10-15

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Recalled by GenoGenix LLC

Reason for Recall

Microbial Contamination of Sterile Products: elevated endotoxin levels

Advertisement
Recall Number
D-0094-2026
Classification
Class I
Status
Ongoing
Category
drug
Initiated
2025-07-30
Reported
2025-10-15
Distribution
US Nationwide.
Code Info
Lot#: GG121624-023, within expiry
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement